malondialdehyde has been researched along with ANS (Autonomic Nervous System) Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulkarni, YA; Suryavanshi, SV | 1 |
| Egorova, LS; Liutkevich, AA; Nesina, IA; Poteriaeva, EL; Tepliakov, GV | 1 |
1 trial(s) available for malondialdehyde and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
[Programs for better health of individuals exposed to increased occupational risk].
Topics: Adaptation, Physiological; Adult; Ambulatory Care; Antioxidants; Autonomic Nervous System Diseases; Baths; Erythrocytes; Health Resorts; Humans; Male; Malondialdehyde; Occupational Diseases; Occupational Health Services; Physical Therapy Modalities; Risk; Siberia; Treatment Outcome; Vibration | 2010 |
1 other study(ies) available for malondialdehyde and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Attenuation of Cardiac Autonomic Neuropathy by Escin in Diabetic Rats.
Topics: Animals; Antioxidants; Autonomic Nervous System Diseases; Catalase; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Escin; Glutathione; Heart; Heart Diseases; Heart Rate; Hemodynamics; Male; Malondialdehyde; Matrix Metalloproteinase 9; Neuroprotective Agents; Oxidative Stress; Rats, Sprague-Dawley; Superoxide Dismutase; Vagus Nerve | 2021 |